AstraZeneca Coronavirus Vaccine Trials Remain Stalled In The U.S.

AstraZeneca released its trial blueprint, detailing the testing of its potential vaccine. Trials are stalled in the US but have resumed in other countries. Testing was paused due to neurological side effects in participants, though the second case was not linked to the vaccine. The FDA has not yet commented on whether trials will continue in the US.

Which company released a trial blueprint for its potential vaccine?

• Pfizer

• Moderna

• Johnson & Johnson

• AstraZeneca

In which countries have AstraZeneca's trials resumed?

• Germany, France, Italy, Spain

• United States, Canada, Mexico

• Britain, Brazil, India, South Africa

• China, Japan, South Korea, Australia

What was the reason for halting AstraZeneca's trials?

• Insufficient volunteers

• Regulatory issues

• Lack of funding

• Serious neurological side effects in participants

What did the company and UK regulators conclude about the second case of side effects?

• It was linked to the vaccine

• It was not linked to the vaccine

• It was inconclusive

• It was due to a different medication

What is the current status of the FDA's decision on the trials?

• The FDA has approved the continuation

• The FDA has rejected the continuation

• The FDA has requested more data

• The FDA has not commented yet